FDA warns ImmunityBio and Patrick Soon-Shiong over misleading Anktiva cancer drug ads on TV and podcast, claiming it can treat all cancers beyond approved use
The FDA warned California-based ImmunityBio for a TV advertisement and podcast that gave the “misleading impression” that Anktiva, the company’s treatment for a type of …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Stay up to date with notifications from The IndependentNotifications can be managed in browser…
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
The agency on Tuesday posted more than 100 letters with 'cease and desist' language to various drugmakers and online prescribing…
The committee reported cases of hematologic malignancies in a follicular lymphoma study dubbed SYMPHONY-1.
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
